JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, P. C.
Right arrow Articles by Friedman, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, P. C.
Right arrow Articles by Friedman, P.

Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril

PC Wong, BG Zimmerman, E Kraft, G Kounenis and P Friedman

The objective of this study was to examine the roles of the blockade of formation of angiotensin II and prostaglandins in the renal vasodilator effect of captopril in conscious salt-replete dogs. Blood pressure was recorded from an indwelling catheter and renal blood flow (RBF) was measured with an electromagnetic flowmeter and an implanted flow probe. Plasma renin activity was measured by radioimmunoassay. The effect of captopril (0.2 mg/kg i.v.) on RBF was compared in dogs given either saralasin (0.5 micrograms/kg min i.a.) or indomethacin (5mg/kg i.v.) with that in dogs given saline vehicle. Control plasma renin activity in these groups of animals before drug treatment ranged from 0.74 to 1.18 ng of angiotensin 1 per ml/hr. Captopril decreased blood pressure from 102 +/- 4 to 92 +/- 4 mm Hg (P less than .01) and increased RBF from 278 +/- 23 to 345 +/- 29 ml/min (25%) (P less than .01) in saline vehicle-treated animals. In the presence of intrarenal infusion of saralasin, captopril did not increase RBF but decreased blood pressure slightly. Captopril still increased RBF by 18% in indomethacin-treated dogs. These results suggest that the renal vasodilator effect of captopril in conscious salt-replete dogs is mainly due to the blockade of angiotensin II formation. Furthermore, the renin-angiotensin system appears to have an influence on renal vascular tone even under these basal conditions.

Volume 219, Issue 3, pp. 646-650, 12/01/1981
Copyright © 1981 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
M C. Lansang and N. K Hollenberg
ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 119 - 124.
[PDF]

Home page
 HypertensionHome page
N. K. Hollenberg
Implications of Species Difference for Clinical Investigation : Studies on the Renin-Angiotensin System
Hypertension, January 1, 2000; 35(1): 150 - 154.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
N. K. Hollenberg and E. Guidi
ACE Inhibitors and Renal Vascular Responses in the Spontaneously Hypertensive Rat
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 161 - 169.
[Abstract] [PDF]

Home page
 HypertensionHome page
N. K. Hollenberg and N. D. L. Fisher
Renal Circulation and Blockade of the Renin-Angiotensin System : Is Angiotensin-Converting Enzyme Inhibition the Last Word?
Hypertension, October 1, 1995; 26(4): 602 - 609.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics.